A prospective 4-year follow-up study of attention-deficit hyperactivity and related

disorders. J. Biederman, S. Faraone, S. Milberger, J. Guite, E. Mick, L. Chen, D.

Mennin, A. Marrs, C. Ouellette, P. Moore, T. Spencer, D. Norman, T. Wilens, I. Kraus
and J. Perrin. Pediatric Psychopharmacology Unit, Massachusetts General Hospital,
Boston, USA. JAMA (Journal of the American Medical Association) & Archives. General
Psychiatry. Vol. 53 No. 5, May 1996

Evidence of familial association between attention deficit disorder and major affective
disorders. J. Biederman, S. V. Faraone, K. Keenan and M. T. Tsuang
Pediatric Psychopharmacology Unit, Massachusetts General Hospital, Boston 02114.
JAMA & Archives. General Psychiatry. Vol. 48 No. 7, July 1991

Attention-Deficit/Hyperactivity Disorder. A Selective Overview. Joseph Biederman.

Biological Psychiatry. Volume 57, Issue 11. Pages 1215-1220 (01 June 2005)

Cortical abnormalities in children and adolescents with attention-deficit hyperactivity

disorder. Sowell Elizabeth R., Thompson Paul M., Welcome Suzanne E.,
Henkenius Amy L.., Toga Arthur W., Peterson Bradley S. Lancet. 2003, vol. 362,
pages. 1699-1707

Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety,

and other disorders. J Biederman, J Newcorn and S Sprich. American Journal of
Psychiatry 1991; 148:564-577

Applied Neuropsychology. Special Issue: Attention Deficit Hyperactivity Disorder (ADHD)

and Neuropsychology. Sam Goldstien and Jack Naglieri. Guest Editors. Lawrence
Erlbaum Associates, Publishers Mahwah, New Jersey. London. Vol 12. No. 2. 2005
Issn 0908-4282

Efficacy of Atomoxetine Versus Placebo in School-Age Girls With Attention-

Deficit/Hyperactivity Disorder. Joseph Biederman, MD*, John H. Heiligenstein, MD,
Douglas E. Faries, PhD, Nora Galil, MD, Ralf Dittmann, MD, PhD||, Graham J. Emslie,
MD¶, Christopher J. Kratochvil, MD#, Harry F. Laws, MD and Kory J. Schuh, PhD
Atomoxetine ADHD Study Group. PEDIATRICS Vol. 110 No. 6 December 2002, pp.
e75

Attention deficit hyperactivity disorder with bipolar disorder in girls: further evidence for a
familial subtype? Faraone S.V.1; Biederman J.; Monuteaux M.C. Abstract at:
I:\IngentaConnect Attention deficit hyperactivity disorder with bipolar disorder in__.htm

A 55-Year-Old Man With Attention-Deficit/Hyperactivity Disorder. Joseph Biederman,

MD, Discussant. JAMA & Archives. Vol. 280 No. 12, September 23, 1998.

Attention-Deficit Hyperactivity Disorder With Bipolar Disorder: A Familial Subtype?.

Faraone, Stephen V. Ph.D.; Biederman, Joseph M.D.; Mennin, Douglas B.A.; Wozniak,
Janet M.D.; Spencer, Thomas M.D. Journal of the American Academy of Child &
Adolescent Psychiatry. 36(10):1378-1390, October 1997

Validity of DSN-IV Subtypes of Attention-Deficit/Hyperactivity Disorder: A family Study

Perspective. Faraone, Stephen V. Ph.D.; Biederman, Joseph M.D.; Friedman, Deborah
B.A.. Journal of the American Academy of Child & Adolescent Psychiatry. 39(3):300-
307, March 2000.

Dopamine, Learning, and Impulsivity: A biological Account of Attention-

Deficit/Hyperactivity Disorder. Jonathan Williams, MBBS, MSc, MRCPsych
Department of Child and Adolescent Psychiatry, Institute of Psychiatry, De Crespigny
Park, Denmark Hill, London, UK. Peter Dayan, Ph.D. Gatsby Computational
Neuroscience Unit, University College London, UK.. Journal of Child and Adolescent
Psychopharmacology. Apr 2005, Vol. 15, No. 2 : 160 -179.

New-Onset Bipolar Disorder in Later Life. Martha Sajatovic, M.D., Frederic C. Blow,
Ph.D., Rosalinda V. Ignacio, M.S., and Helen C. Kales, M.D. American Journal of
Geriatric Psychiatry 13:282-289, April 2005

Meta-analysis of family-based association studies between the dopamine transporter

gene and attention deficit hyperactivity disorder. Purper-Ouakil, D. a; Wohl, M. a b;
Mouren, M. C. a c; Verpillat, P. b; Ades, J. b c; Gorwood, P. b c. Psychiatric Genetics.
15(1):53-59, March 2005.

Stimulant Drugs and ADHD Basic and Clinical Neuroscience. Editied by Mary V.
Solanto, May F.T. Sernsten, F. Xavier Castellanos. Oxford University Press 2001.

Attention Genes and ADHD. Edited by Florence Levy and David Hay. Brunner-
Routledge. Taylor & Francis Group. 2001.

Clinical Trials. A Practical Approach. Stuart J. Pocock. A Wiley Medical Publication.

John Wiley & Sons. First printed 1983. Reprinted December 1991.

Executive Functions and Attention Deficit Hyperactivity Disorder: Implications of two

conflicting views. Thomas E. Brown. International Journal of Disability, Development and
Education. Vol 53, No 1, March 2006. pp 35 – 46

Value of 99m Tc_TRODAT-1 SPECT to predict clinical response to methylphenidate

treatment in adults with attention deficit hyperactivity disorder. La Fougere C, Krause J,
Krause KH, Josef Gildehaus F, Hacker M, Koch W, Hahn K, Tatsch K and Dresel S.
Nuclear Medicine Communications. Vol 27 No 9. pages 733 –737.

Right Parietal Dysfunction in Children with Attention Deficit Hyperctivity Disorder

Combined Type: A functional MRI Study. Vance A, Silk TJ, Casey M, Rinehart NH,
Bradshaw Jl, Bellgrove MA, Cunnington R. Molecular Psychiatry (advance on line
publication). 1 May 2007 doi:10.1038/sh.np 4001999

Fluoxetine Monotherapy in Attention-Deficit/Hyperactivity Disorder and Comorbid Non-

Bipolar Mood Disorders in Children and Adolescents. Humberto Quintana, Grant J.
Butterbaugh, William Purnell and Ann K. Layman. Journal Child Psychiatry and Human
Development Issue Volume 37, Number 3 February, 2007Pages 241-253

Differentiating Bipolar Disorder in Turkish Prepubertal Children with Attention-Deficit

Hyperactivity Disorder. Rasim Somer Diler, Sukru Uguz, Gulsah Seydaoglu, Nese Erol,
Ayse Avci. 2007. Bipolar Disorders. Volume 9 Issue 3 Pages 243 May 2007
Diagnosis and treatment of adults with attention-deficit/hyperactivity disorder.CNS
Spectrums. Biederman J, Wilens TE, Spencer TJ, Adler LA. Spectrums. 2007 Apr;12(4
Suppl 6):1-15. PMID: 17426673 [PubMed - in process]

A review of driving risks and impairments associated with attention-deficit/hyperactivity

disorder and the effects of stimulant medication on driving performance. Journal of
Safety Research. 2007;38(1):113-28. Epub 2007 Feb 15. Barkley RA, Cox D.

Fatty Acid Metabolism in Neurodevelopmental Disorder: A New Perspective in

Associations Between Attention-deficit Hyperactivity Disorder, Dyslexia, dyspraxia and
the Autistic Spectrum. Richardson, M.A.Ross. Prostaglandins, Leukotrienes and
Essential Fatty Acids (200) 63(2) 000-000

The age-dependent decline of attention deficit hyperactivity disorder - a meta-analysis of

follow-up studies. Stephan Faraone, Joseph Biederman and Eric Mick. Psychological
Medicine. 2005. 35, 1 – 7. Cambridge University Press. Doi:10.1017/S003329170500IX.

Is there a relationship between attention deficit hyperactivity disorder and bipolar

disorder? Kent L, Craddock N. Department of Psychiatry. University of Brimingham,
Queen Elizabeth Psychiatric Hospital. Birmingham. B15 2QZ. U.K. Journal of Effective
Disorders 2003. Feb:73(3):211-21.

Can adults with attention-deficit/hyperactivity disorder be distinguished from those with

comorbid bipolar disorder? Wilens T.E., Biederman J., Wozniak J., Gunawardens S.,
Wong J., Monuteaux M. Clinical Research Program in Pediatric Psychoparmacology,
Massachusetts General Hospital. Harvard Medical School. Boston. Biological Psychiatry
2003 July 1:54(1):1-8

Current Concepts of the Neurobiology of Attention-Deficit/Hyperactivity Disorder.

Biederman J., Faraone S.V. Pediatric Psychopharmacology Unit of the Child Psychiatry
Service. Massachusetts General Hospital and Harvard Medical School. USA. Journal of
Attgention Disorders. 2002:6 Suppl 1:S7 – 16.

Atomoxetine in the Treatment of Children and Adolescents With Attention-

Deficit/Hyperactivity Disorder. A Randomized, Placebo-Controlled, Dose-Response
Study. David Michelson, Douglas Faries, Joachim Wernicke, Douglas Kelsey, Katherine
Kendrick, F. Randy Salle, Thomas Spencer, and the Atomoxetine ADHD Study Group.
From the Lilly Research Laboratories and Indianan University School of Medicine.
Indianapolis. Indiana University of Cincinnati, Cincinnati, Ohio and Massachusetts
General Hospital, Boston Massachusetts. Pediatrics Vol. 108 No. 5 November 2001. p
e83

General Bipolar Information The Black Dog Institute. The Black Dog Institute is an
educational, research, clinical and community-oriented facility offering specialist
expertise in mood disorders. www.blackdoginstitute.org.au/factsheets/index.cfm

Bipolar World. One of the mission statements: to provide timely information and
education about Bipolar Disorder - what it is, how it is diagnosed and how it is treated .
http://www.bipolarworld.net/
Developmental Trajectories of Brain Volume Abnormalities in Children and Adolescents
with Attention-Deficit/Hyperactivity Disorder. F. Xavier Castellanos, MD. Patti R. Lee,
MD. Wendy Sharp, MSW. Neal O. Jeffries, PhD. Deanna K. Greenstein, PhD. Liv S.
Clasen. PhD. Jonathan D. Blumenthal, MA. Regina s. James, MD. Christen L. Ebens,
BA. James M. Walter, MA. Alex Zijdenbos, PhD. Alan C. Evans, PhD. Jay N. Gledd, MD.
Judith L Rapoport. MD. The Journal of the American Medical Association. Vol 288 No
14, October 9, 2002.

McMan's Depression and Bipolar Web. Bipolar Disorder FAQ Part I - III - Overview to
Bipolar. http://www.mcmanweb.com/bpfaq1.htm#What%20is%20bipolar%20disorder

The website of R. Kaan Ozbayrak, MD about Asperger’s Disorder:

http://www.aspergers.com/

Wikipedia Asperger’s page: http://en.wikipedia.org/wiki/Asperger_syndrome

Tony Attwood’s website. Dr Attwood is a psychologist and is an authority on Asperger’s

Disorder in Australia: http://www.tonyattwood.com.au/

The Complete Guide to Asperger’s Syndrome. Tony Attwood. Published by Jessica

Kingsley. London UK.

Eli Lilly Australia Pty Ltd’s website about Bipolar in Australia:

http://www.bipolar.com.au/understanding/

International Consensus Statement on AD/HD of January 2002:

http://www.russellbarkley.org/adhd-consensys.htm

Dr. Barkley’s talk in San Francisco (2001) – model of AD/HD-C:

http://www.schwablearning.org/articles.asp?r=54

Dr. Barkley’s educational material for Health Care Professionals:

http://www.continuingedcourses.net/active/courses/courses.php

Understanding ADHD (Attention Deficit Hyperactivity Disorder). Dr. Christopher Gree

and Dr. Kit Chee. Transworld Publishing a division of Random House Publishing
Australia Pty Ltd. 1994 – 2001.

Asperger’s Syndrome. A guide for Parents and Professionals. Tony Attwood. Jessica
Kingsley Publishers. London UK. 1998.

The Attention Deficit Answer Book. The Best Medications and Parenting Strategies for
Your Child. Alan Wachte, M.D with Michael Boyette. Published by the Penguin Group.
January 1998.

ADHD Recognition Reality and Resolution. Geoffrey Kewley. First published in 1999 by
LAC Press (Learning Assessment Centre) West Sussex. This edition published by
Australian Council for Education Research Ltd. Camberwell. Melbourne Victoria.
Australia.
Quantitative Brain Magnetic Resonance Imaging in Girls with Attention-
Deficit/Hyperactivity Disorder. Castellanos F. Xavier, Giedd Jay N, Berquin Patrick C,
Walter James M, Sharp Wendy, Tran Thanhian, Vaituzis A Catherine, Blumenthal
Jonathan D, Nelson Jean, Bastain Theresa M, Zijdenbos Alex, Evans Alan C, Rapoport
Judith L.

Does Stimulant Therapy of Attention-Deficit/Hyeractivity Disorder Beget Later Substance

Abuse? A Meta-analytic Review of the Literature. Timothy E Willens MD, Stephen V.
Faraone PhD, Joseph Biederman MD, and Samantha Guawardene BS. Pediatrics Vol
111 No. 1 January 2003. pp 179 – 185

The Role of Vascular Risk factors in Late Onset Bipolar Disorder. Hari Subramaniam,
Michael S. Dennis and E. Jane Byrne. International Journal of Geriatric Psychiatry.
Published online by Wiley InterScience.

Silent Cerebral Infarctions in Patients With Late-Onset Mania. From the Department of
Psychiatry and Neurosciences, Hiroshima University School of Medicene. (T.F.S.Y) and
the Department of Psychiatry and Neurology, Hiroshima Prefectural Hospital (Y.T).
Hiroshima. Japan.

New Onset Bipolar Disorder in Later Life. Martha Sajatovic, M.D, Frederic C. Blow PhD,
Rosealinda V. Ignacio MS, and Helen C. Kales MD. American Journal of Geriatric
Psychiatry.

Early – Versus Late-Onset Bipolar II Disorder. Franco Benassi, MD. Department of

Psychiatry. Morgagni Public Hospital Forli .Italy. Journal of Psychiatry and
Neuroscience. Vol 25, No 1. 2000.

The Scientific Foundation for Understanding Attention-Deficit/Hyperactivity Disorder as a

Valid Psychiatric Disorder. Stephen V. Faraone. Eur Child Adolescent Psychiatry. (2005)
14:1-10 DOI 10.1007/s00787-005-0429-z

Electroencephalogram Differences in Two Subtypes of Attention-Deficit/Hyperactivity

Disorder. Adam R Clarke, Robert J Barry, Rory McCarthy and Mark Selikowitz.
Psychophysiology 38 (2001) 212 – 221. Cambridge University Press. Printed in the
USA.

Electroencephalographic Biofeedback in the Treatment of Attention-Deficit/Hyperactivity

Disorder. Vincent j. Monastra, Steven Lynn, Michael Linden, Joel F. Lubar, John
Gruzelier and Theodore J La Vague. Applied Psychophysiology and Biofeedback Vol. 30
No 2. June 2005.

Blood Pressure Changes Associated with Medication Treatment of Adults with Attention-
Deficit/Hyperactivity Disorder. Timothy E. Willens, MD. Paul G Hammerness MD. Joseph
Biederman MD. Anne Kwon MS. Thomas J. Spencer MD. Sarah Clark BA. Megan Scott
BS. Amy Podolski BA. Jeffrey W. Ditterline BA. Matthew C Morris BA. And Hadly Moore
BA. Journal of Clinical Psychiatry 66:2, February 2005

Comorbid ADHD is Associated with Altered Patterns of Neuronal Activation in

Adolescents with Bipolar Disorder Performing a Simple Attention Task. Caleb M Adler,
Melissa P DelBello, Niel P Millsa, Vince Schmithorst, Scott Holland and Stephen M
Strakowski. Bipolar Disorders. Volume 7 Issue 6 Page 577-588 December 2005.

Regional Cerebral Blood Flow in Children With Attention Deficit Hyperactivity Disoder: A
Comparison Before and After Methylphenidate Treatment. Jae Sung Lee, Boong Nyun
Kim, Eunjoo Kang, Dong Soo Lee, Yu Kyeong Kim, June-Hey Chung, Myung Chul Lee
and Soo Churl Cho. Human Brain Mapping. 24:157 – 164. 2005

Bupropion XL in Adults with Attention-Deficit/Hyperactivity Disorder: a Randoized

placebo-controlled Study. Wilens TE, Haight BR, Horrigan JP, Kudziak JJ, Rosenthal
NE, Connor DF, HamptonKD, Richard NE, Modell JG. Biol Psychiatry 2005. April 1:57(7)
793-801.

Hippocampal 1H MRS in Patients with Bipolar Disorder Taking Valproate Versus

Valproate Plus Quetiapine. Murad Atmaca, Hanefi Yildirum, Huseyin Ozemire Erkin
Ogur and Retan Tezcan. Psychological Medicine (2007) 37:121 – 129 Cambridge
University Press.

ADHD Combined Type and ADHD Predominantly Inattentive Type Are Distinct and
Unrelated Disorders. Richard Milich, Amy C. Balentine, Donald R. Lynam. (2001)Clinical
Psychology. Science and Practice 8 (4), 463 – 488.

Attention-Deficit/Hyperactivity Disorder in Adults: An Overview. Stephen V. Faraone,

Joseph Biederman, Thomas Spencer, Tim Wilens, Larry J Seidman, Eric Mick and Alysa
E. Doyle. Society of Biological Psychiatry. 2000. PH S0006-3223(00)00889-1

Attention Deficit/Hyperactivity Disorder Across the Lifespan. Timothy E. Wilens, Joseph

Biederman and Thomas J Spencer. Annual Reviews Medical. 2002. 53:113 – 131

Variability in Time Reproduction: Difference in ADHD Combined and Inattentive

Subtypes. Mullins Celine BA, Bellgrove Mark PhD, Gill Michael MD, Robertson Ian PhD.
Journal of American Academy of Child & Adolescent Psychiatry. 44(2):169 – 176.
February 2005.

Driving-Related Risks and Outcomes of Attention Deficit Hyperactivity Disorder in

dolescents and Young Adults: A 3 to 5 Year Follow-up Study. Russell A. Barkley PhD.
David C. Guevremont PhD, Arthur D. Anastopoulos PhD, George J DuPaul PhD, and
Tern L Shelton PhD. All from the Department of Psychiatry, Neurology and Pediatrics.
University of Massachusetts Medical Center. Worcester.

Behavioral Characteristics of DSM-IV ADHD Subtypes in School-Based Population.

Miranda Gaub and Caryn L. Carlson. Journal of Abnormal Child Psychology. Volume 25,
Number 2 April 1997 pages 103 – 111.

Working Memory Impairment in Children with Attention-Deficit Hyperactivity Disorder

With and Without Comorbid Language Learning Disorders. Rhonda Martinusses and
Rosemary Tannock. Journal of Clinical and Experimental Neuropsychology. Volume 28,
Number 7 October 2006. Pages 1073 – 1094.

Patterns of Psychiatric Comorbidity, Cognition and Psychosocial Functioning in Adults

with Attention Deficit Hyperactivity Disorder. J Biederman, SV Faraone, T Spencer, T
Wilens, D Norman, KA Lapey, E Michk, BK Lehman and A Doyle. American Journal of
Psychiatry 1993: 150:1792 – 1798.

Should Sluggish Cognitive Tempo Symptoms be Included in the Diagnosis of Attention-

Deficit/Hyperactivity Disorder? Todd RD, Rasmussen EF, Wood C, Levy F, Hay DA.
Journal of American Academy of Child & Adolescent Psychiatry 2004. May:43(5):588 –
597.

Does Stimulant Therapy of Attention-Deficit/Hyperactivity Disorder Beget Later

Substance Abuse? A Meta-analytic Review of the Literature. Timothy E Wilens MD,
Stephen V. Faraone PhD, Joseph Biederman MD, and Samantha Gunawardene BS.
Pediatrics Vol 111 No 1 January 2003. pages 179 – 185.

Effect of Stimulant Medication on Driving Performance of Young Adults with Attention-

Deficit Hyperactivity Disorder: A Preliminary Double-Blind placebo Controlleld Trail. Cox
DJ, Merkel RL, Kovatchev B. Seward R. Journal of Nervous and Mental Disease. 2000
April:188(4):230 – 234.

Mangement of Attention Deficit Hyperactivity Disorder: A Parental Perspective. PE

Concannon and YP Tang. Journal of Paediatrics and Child Health. Volume 41 Page 625
– December 2005.

Behavioral Characteristics of DSM-IV ADHD subtypes in a School-Based Population.

Miranda Gaub and Caryn L. Carlson. Journal of Abnormal Child Psychology. Behavioral
Science. Volume 25, Number 2 April 1997.

Instability of the DSM-IV Subtypes of ADHD From Preschool Through Elementary

School. Benjamin B. Lahey PhD, William E. Pelham PhD. Jan Loney PhD. Steve S. Lee
PhD. Erik Willcutt PhD. Archives of General Psychiatry 2005:62:896 – 902.

Role of Executive Function in ADHD. James M Swanson PhD. Journal of Clinical

Psychiatry 2003;64 (suppl 14).

Distributed Grey and While Matter Deficits in Hyperkinetic Disorder: MRI Evidence for
Anatomical Abnormality in an Attentional Network. S. Overmeyer, ET Bullmore, J
Suckling, A Simmons, SCR Williams, PJ Santosh and E Talor. Psychological Medicine
2001. 31 1425 – 1435.

Validity of the Executive Function Theory of Attention-Deficit/Hyperactivity Disorder: A

Metal-Analytic Review. Erik G Willcutt, Alysa E Doyle, Joel T Nigg, Stephen V Faraone,
and Bruce F Pennington. Biological Psychiatry 2005; 57:1336 – 1346

Social Functioning and Emotional Regulation in the Attention Deficit Hyperactivity

Disorder Subtypes. Jennifer Wheeler Maedgen and Caryn L Carlson. Journal of Clinical
Child Psychology. 2000. Vol 29 No 1 30 – 42

Sluggish Cognitive Tempo Predicts a Different Pattern of Impairment in the Attention

Deficit Hyperactivity Disorder Predominantly Inattentive Type. Carlson CL and Mann M.
Jounral of Clinical Child and Adolescent Psychology 2002. Mar;31(1):123 – 129.
Methylhenidate: Mechanism of Action and Clinical Update. Lawrence Scahill PhD,RN.
Deirdre Carroll, MSN,RN. and Kathleen Burke PhD RN. Journal of Child Adolescence
Psychiatric Nursing. Vol 17, Number 2 April-June 2004